NIH-funded research NIH-funded research

How changes in cell signaling affect aging and diseases like cancer and arthritis

Official title: Transcription Factor Network-Mediated Modulation of Transitional Senescence States

Funded at Rutgers Biomedical and Health Sciences · NIH-10941654 · Data updated 2026-11-12

This study is looking at how certain proteins that control our genes might affect aging and diseases like cancer and osteoarthritis, with the hope of finding new ways to help people stay healthier as they get older.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$336,070
NIH project number1R35GM155447-01
Project IDNIH-10941654 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing age-related conditions, such as osteoarthritis or cancer.

Less likely to help

Patients with acute, non-degenerative conditions or those not affected by aging-related diseases may not benefit from this research.

What this research studies

This research investigates how transcription factors, which are proteins that help control the activity of genes, influence the aging process and the development of diseases such as cancer and osteoarthritis. By examining how these factors can change in response to various signals, the study aims to understand how cells can lose their identity and enter a state known as senescence, which is linked to aging and disease. The researchers will explore ways to manipulate these transitional states to potentially develop new therapies that could improve health outcomes for patients. This work involves advanced techniques to analyze cellular responses and could lead to significant insights into cell function and disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing aging-related diseases and improving overall health.

How similar studies have gone: Other research has shown promise in manipulating cellular states for therapeutic purposes, indicating that this approach could be viable.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Martinez Zamudio, Ricardo Ivan — Rutgers Biomedical and Health Sciences
  • Study coordinator: Martinez Zamudio, Ricardo Ivan

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.